Orapred
NDC Package 59630-702-48

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Orapred is prednisolone is used to treat conditions such as arthritis, blood disorders, severe allergic reactions, certain cancers, eye conditions, skin/kidney/intestinal/lung diseases, and immune system disorders. Marketed by Shionogi Inc., this product is identified by NDC 59630-702 and is authorized under FDA application NDA021959.

Identification & Billing

NDC Package Code
59630-702-48
Package Description
8 BLISTER PACK in 1 CARTON / 6 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK
Product Code
11-Digit Billing Format
59630070248
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
8 EA

Clinical Specifications

Proprietary Name
Orapred Odt
Dosage Form
-
Usage Information
Prednisolone is used to treat conditions such as arthritis, blood disorders, severe allergic reactions, certain cancers, eye conditions, skin/kidney/intestinal/lung diseases, and immune system disorders. It decreases your immune system's response to various diseases to reduce symptoms such as swelling, pain and allergic-type reactions. This medication is a corticosteroid hormone. Prednisolone may also be used with other medications in hormone disorders.

Regulatory & Marketing

Labeler Name
Shionogi Inc.
FDA Application #
NDA021959
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
06-01-2006
End Marketing Date
08-31-2015
Listing Expiration
08-31-2015
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 59630-702-48 identifies a specific commercial package of 8 blister pack in 1 carton / 6 tablet, orally disintegrating in 1 blister pack of Orapred Odt, labeled by Shionogi Inc.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Shionogi Inc. on June 01, 2006. The current certification is valid through August 31, 2015.

What are the primary indications for this medication?

Prednisolone is used to treat conditions such as arthritis, blood disorders, severe allergic reactions, certain cancers, eye conditions, skin/kidney/intestinal/lung diseases, and immune system disorders. It decreases your immune system's response to various diseases to reduce symptoms such as swelling, pain and allergic-type reactions. This medication is a corticosteroid hormone. Prednisolone may also be used with other medications in hormone disorders.

How is this Shionogi Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 59630070248. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 8 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
59630-702-48
11-Digit CMS (5-4-2)
59630-0702-48

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.